The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas
Open accessAbstract
BACKGROUND & AIMS: Differences in efficacy of radiofrequency ablation (RFA) and surgical resection (SR) are not clear for patients with hepatocellular carcinoma (HCC). METHODS: From 2002 to 2007, 419 patients with HCCs ≤5 cm were enrolled consecutively in the study. Among these patients, 190 and 229 patients received RFA and SR, respectively, as their first treatment. Factors were analyzed in terms of overall survival and recurrence by multivariate analysis and propensity score matching analysis. RESULTS: The SR group had younger age, a higher male-to-female ratio, higher prevalence of hepatitis B virus, lower prevalence of hepatitis C virus, better liver function reserve, and larger tumor size than the RFA group. The cumulative 5-year overall survival rates were 79.3% in the SR group and 67.4% in the RFA group. During the follow-up period, tumors recurred in 244 patients in a median time of 14.5 ± 15.7 months. Before propensity-score matching, the RFA group had shorter overall survival time (P = .009) and higher tumor recurrence rate (P < .001) than the SR group. After matching, RFA was comparable to SR in overall survival time (P = .519), but the RFA group still had a greater incidence of tumor recurrence (P < .001). In patients with Barcelona Clinic Liver Cancer (BCLC) stage 0 HCC, RFA was as effective as SR for overall survival time and recurrence. CONCLUSIONS: Patients with small HCCs have a higher rate of tumor recurrence following RFA than surgery, but overall survival rates are comparable between therapies. RFA is as effective as surgery in patients with BCLC stage 0 HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Romito, R., Schiavo, M., Mariani, L., Camerini, T., Bhoori, S., Capussotti, L., Calise, F., Pellicci, R., Belli, G., et al. (2006) · Hepatology · doi:10.1002/hep.21415 · Cited by 367
Cited by
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Zhong, J.-H., Ke, Y., Gong, W.-F., Xiang, B.-D., Ma, L., Ye, X.-P., Peng, T., Xie, G.-S., & Li, L.-Q. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000236 · Cited by 464
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
Nault, J.-C., Sutter, O., Nahon, P., Ganne-Carrié, N., & Séror, O. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.004 · Cited by 395
Wang, J.-H., Wang, C.-C., Hung, C.-H., Chen, C.-L., & Lu, S.-N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.020 · Cited by 348
Treatment of Hepatocellular Carcinoma: A Systematic Review
Lin, S., Hoffmann, K., & Schemmer, P. (2012) · Liver Cancer · doi:10.1159/000343828 · Cited by 334
Metadata
- Authors
- Hung, H., Chiou, Y., Hsia, C., Su, C., Chou, Y., Chiang, J., Kao, W., Huo, T., Huang, Y., Su, Y., Lin, H., Lee, S., & Wu, J.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 9
- Issue
- 1
- Pages
- 79-86
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2170839371
- Cited by
- 187
- References
- 1
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas. https://app.cochat.ai/papers/10.1016/j.cgh.2010.08.018
- The paper
- Hung, H., Chiou, Y., Hsia, C., Su, C., Chou, Y., Chiang, J., Kao, W., Huo, T., Huang, Y., Su, Y., Lin, H., Lee, S., & Wu, J. (2011). Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular Carcinomas. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2010.08.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.